A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.

BACKGROUND Clostridium botulinum strain IBCA10-7060, isolated from a patient with infant botulism, produced botulinum neurotoxin type B (BoNT/B) and another BoNT that, by use of the standard mouse bioassay, could not be neutralized by any of the Centers for Disease Control and Prevention-provided monovalent polyclonal botulinum antitoxins raised against BoNT types A-G. METHODS AND RESULTS  The combining of antitoxins to neutralize the toxicity of known bivalent C. botulinum strains Ab, Ba, Af, and Bf also failed to neutralize the second BoNT. Analysis of culture filtrate by double immunodiffusion yielded a single line of immunoprecipitate with anti-A, anti-B, and anti-F botulinum antitoxins but not with anti-E antitoxin. A heptavalent F(ab')2 botulinum antitoxin A-G obtained from the US Army also did not neutralize the second BoNT. An antitoxin raised against IBCA10-7060 toxoid protected mice against BoNT/B (Okra) and against the second BoNT but did not protect mice against BoNT/A (Hall) or BoNT/F (Langeland). CONCLUSION The second BoNT thus fulfilled classic criteria for being designated BoNT/H. IBCA10-7060 is the first C. botulinum type Bh strain to be identified. BoNT/H is the first new botulinum toxin type to be recognized in >40 years, and its recognition could not have been accomplished without the availability of the mouse bioassay.

[1]  Giménez Df,et al.  Studies on strain 84 of Clostridium botulinum. , 1970 .

[2]  J. Leuchs.  Beiträge zur Kenntnis des Toxins und Antitoxins des Bacillus botulinus , 1910, Zeitschrift für Hygiene und Infektionskrankheiten.

[3]  Gary Xie,et al.  Molecular characterization of a novel botulinum neurotoxin type H gene. , 2014, The Journal of infectious diseases.

[4]  K. P. Murphy,et al.  Janeway's immunobiology , 2007 .

[5]  S. Arnon,et al.  Dual Toxin-Producing Strain of Clostridium botulinum Type Bf Isolated from a California Patient with Infant Botulism , 2004, Journal of Clinical Microbiology.

[6]  S. Seifert,et al.  Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. , 2001, Annals of emergency medicine.

[7]  I. Scheibel,et al.  Preliminary report on the isolation of an apparently new type of CI. botulinum. , 2009, Acta pathologica et microbiologica Scandinavica.

[8]  Leonard A. Smith,et al.  Analysis of Clostridium botulinum Serotype E Strains by Using Multilocus Sequence Typing, Amplified Fragment Length Polymorphism, Variable-Number Tandem-Repeat Analysis, and Botulinum Neurotoxin Gene Sequencing , 2011, Applied and Environmental Microbiology.

[9]  D. F. Giménez.  Clostridium botulinum subtype Ba. , 1984, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.

[10]  N. Jewell,et al.  Human botulism immune globulin for the treatment of infant botulism. , 2006, The New England journal of medicine.

[11]  E. Ermengem.  Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus , 1897, Zeitschrift für Hygiene und Infektionskrankheiten.

[12]  M. Hellmich,et al.  Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  A. Bowdler.  The complete spleen : structure, function, and clinical disorders , 2002 .

[14]  Giménez Df,et al.  Another type of Clostridium botulinum. , 1970 .

[15]  C. Hatheway,et al.  Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms , 1994, Journal of clinical microbiology.

[16]  F. Delille,et al.  Intoxication botulique mortelle due à une souche de Clostridium botulinum de type AB , 1983 .

[17]  A. Denman.  Autoimmunity, Genetic, Immunologic, Virologic and Clinical Aspects , 1979 .

[18]  Giménez Df.  Clostridium botulinum subtype Ba. , 1984 .

[19]  L. O. Ticknor,et al.  Genetic Diversity among Botulinum Neurotoxin-Producing Clostridial Strains , 2006, Journal of bacteriology.

[20]  E. V. Ermengem.  A New Anaerobic Bacillus and Its Relation to Botulism , 1979 .

[21]  J. B. Gunnison,et al.  South African Cultures of Clostridium Botulinum and Parabotulinum. XXXVII: With a Description of CL. Botulinum Type D, N.SP. , 1929 .

[22]  I. A. Bengtson.  Preliminary Note on a Toxin-Producing Anaerobe isolated from the Larvae of Lucilia caesar. , 1922 .

[23]  D. F. Giménez,et al.  Studies on strain 84 of Clostridium botulinum. , 1970, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale.

[24]  G. S. Burke.  NOTES ON BACILLUS BOTULINUS , 1919, Journal of bacteriology.

[25]  G. L. Lombard,et al.  Atypical toxin variant of Clostridium botulinum type B associated with infant botulism , 1981, Journal of clinical microbiology.

[26]  Brian H. Raphael,et al.  Sequence Diversity of Genes Encoding Botulinum Neurotoxin Type F , 2010, Applied and Environmental Microbiology.

[27]  J N Weinstein,et al.  Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice. , 1986, Cancer research.

[28]  D. M. Weir,et al.  Handbook of experimental immunology , 1967 .

[29]  D. F. Giménez,et al.  Another type of Clostridium botulinum. , 1970, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale.

[30]  M. C. dos Santos,et al.  Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab')2 fragments. , 1994, Toxicon : official journal of the International Society on Toxinology.

[31]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[32]  F. A. Zapatka,et al.  Immunodiffusion method for detection of type A Clostridium botulinum , 1981, Applied and environmental microbiology.

[33]  P. Aureli,et al.  Differentiation of the Gene Clusters Encoding Botulinum Neurotoxin Type A Complexes in Clostridium botulinum Type A, Ab, and A(B) Strains , 2004, Applied and Environmental Microbiology.

[34]  N. Dover,et al.  Clostridium botulinum Strain Af84 Contains Three Neurotoxin Gene Clusters: Bont/A2, bont/F4 and bont/F5 , 2013, PloS one.

[35]  L. Weiss,et al.  The Microanatomy of the Mammalian Spleen , 2002 .

[36]  Philip K. Russell,et al.  Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.

[37]  E. Hazen.  A Strain of B. Botulinus Not Classified as Type A, B, or C , 1937 .

[38]  R. Fagan,et al.  Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  E. Kabat.  Structural Concepts in Immunology and Immunochemistry , 1968 .

[40]  H. W. Walker,et al.  Detection of botulinal toxins by immunodiffusion. , 1968, Applied microbiology.

[41]  K. F. Meyer,et al.  Clostridium Botulinum Type E , 1936 .